CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Cullinan Therapeutics, Inc. (CGEM) on Thursday reported a loss of $48.5 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of 74 cents per share.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 78 cents per share.
Cullinan Therapeutics shares have fallen 37% since the beginning of the year. The stock has declined 74% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEM at https://www.zacks.com/ap/CGEM
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
